Role of hormonal and reproductive factors in the etiology and treatment of uterine leiomyoma

Recent Progress in Hormone Research

Volumn 57, Issue , 2002, Pages 277-294

  Walker, Cheryl L ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID HORMONE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE RESPONSE; MOUSE; NONHUMAN; PREGNANCY; RAT; TUMOR CELL LINE; TUMOR GROWTH; UTERUS MYOMA;

ANIMALS; DISEASE MODELS, ANIMAL; ESTROGENS, NON-STEROIDAL; FEMALE; HORMONES; HUMANS; LEIOMYOMA; PHENOTYPE; RATS; REPRODUCTION; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0036376206     PISSN: 00799963     EISSN: None     Source Type: Journal    
DOI: 10.1210/rp.57.1.277     Document Type: Article

References (80)

1. Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis
2. Towards an understanding of breast cancer etiology
3. Treatment of uterine fibroids: Current findings with gonadotropin-releasing hormone agonists
4. Is the risk of cancer of the corpus uteri reduced by a recent pregnancy? A prospective study of 765,756 Norwegian women
5. Expression of connexin-43 in human myometrium and leiomyoma
6. Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures
7. Therapeutic uses of gonadotropin-releasing hormone analogs
8. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas
9. Estrogen receptor gene expression in human uterine leiomyomata
10. Regulation of apoptosis in uterine leiomyomata
11. Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat
12. Uterine leiomyomata: Etiology, symptomatology, and management
13. Pregnancy, parturition, and prostaglandins: Defining uterine leiomyomas
14. Diet and uterine myomas
15. Use of oral contraceptives and uterine fibroids: Results from a case-control study
16. Expression of the gap junction protein connexin-43 is increased in the human myometrium toward term and with the onset of labor
17. Hyalinization and cellular changes in uterine leiomyomata after gonadotropin releasing hormone agonist therapy
18. Epidemiology of breast cancer. Findings from the nurses health study
19. Epidemiology of myomas
20. The frequency of uterine leiomyomas
21. Cortical and trabecular bone mineral content in women with endometriosis: Effect of gonadotropin-releasing hormone agonist and danazol
22. Sex steroid receptors in human myometrium and fibroids: Changes during the menstrual cycle and gonadotropin-releasing hormone treatment
23. Rodent model of reproductive tract leiomyomata. Clinical and pathological features
24. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status
25. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
26. Role of reproductive factors on the risk of endometrial cancer
27. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: The estrogen threshold hypothesis
28. Preclinical studies of raloxifene and related compounds
29. Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators
30. Efficacy of LGD1069 (Targretin), a retinoid X receptor-selective ligand, for treatment of uterine leiomyoma
31. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): An RXR-selective ligand
32. Hormonal prevention of breast cancer: Mimicking the protective effect of pregnancy
33. Tamoxifen as risk factor for carcinoma of corpus uteri
34. Subsite (cervix/endometrium)-specific risk and protective factors in uterus cancer
35. Estrogenic effects of organochlorine pesticides on uterine leiomyoma cells in vitro
36. Rodent model of reproductive tract leiomyomata: Establishment and characterization of tumor-derived cell lines
37. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo
38. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen
39. Organochlorine exposure and risk of breast cancer
40. Enhanced deoxyribonucleic acid damage and repair but unchanged apoptosis in uterine leiomyomas treated with gonadotropin-releasing hormone agonist
41. Epidemiology of susceptibility to breast cancer
42. Epidemiologic analysis of breast and gynecologic cancers
43. Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium
44. The role of tamoxifen in the treatment and prevention of breast cancer
45. Mitotic activity in uterine leiomyomas during the menstrual cycle
46. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
47. Epidemiology and prevention of breast cancer
48. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis
49. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer
50. Childbearing at older age and endometrial cancer risk
51. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race
52. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata
53. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking
54. Increased expression of Bcl-2 protein in human uterine leiomyoma and its upregulation by progesterone
55. Potential role of tamoxifen in prevention of breast cancer
56. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy
57. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women
58. Oral contraceptive use and risk of uterine fibroids
59. Reproductive factors and risk of uterine fibroids
60. Uterine myomas and smoking. Results from an Italian study
61. Epidemiologic characteristics of women with uterine fibroids: A case-control study
62. Risk factors among young women with endometrial cancer: A Danish case-control study
63. Biology of uterine myomas and myometrium in vitro
64. Risk factors for uterine fibroids: Reduced risk associated with oral contraceptives
65. Myomas, reproductive function, and pregnancy
66. Role of hormones in mammary cancer initiation and progression
67. DDT and its metabolites in leiomyomatous and normal human uterine tissue
68. Rapid loss of oestrogen and progesterone receptors in human leiomyoma and myometrial explant cultures
69. Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats
70. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: Prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy
71. Regulation of the human menstrual cycle
72. Natural history of uterine leiomyomas in pregnancy
73. Distribution of the A and B forms of the progesterone receptor messenger ribonucleic acid and protein in uterine leiomyomata and adjacent myometrium
74. Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma
75. Protective effect of pregnancy for development of uterine leiomyoma
76. Blood levels of organochlorine residues and risk of breast cancer
77. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease
78. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene
79. Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat